09/05/2024 6:52 PM | Bellemin Jean-Marc (Reporting) Iovance Biotherapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/05/2024 6:53 PM | BILINSKY IGOR (Reporting) Iovance Biotherapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/05/2024 6:54 PM | GRAF FINCKENSTEIN FRIEDRICH (Reporting) Iovance Biotherapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/05/2024 6:56 PM | Iovance Biotherapeutics (Issuer) Vogt Frederick G (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/09/2024 4:16 PM | Iovance Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/08/2024 4:10 PM | Iovance Biotherapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
07/17/2024 7:00 PM | BILINSKY IGOR (Reporting) Iovance Biotherapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
07/17/2024 7:01 PM | GRAF FINCKENSTEIN FRIEDRICH (Reporting) Iovance Biotherapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/17/2024 7:01 PM | Iovance Biotherapeutics (Issuer) Vogt Frederick G (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/28/2024 6:30 AM | Iovance Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/13/2024 5:00 PM | Dukes Iain D. (Reporting) Iovance Biotherapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/13/2024 5:00 PM | Iovance Biotherapeutics (Issuer) Maynard Ryan D (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/13/2024 5:01 PM | Iovance Biotherapeutics (Issuer) WEISER MICHAEL (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/13/2024 5:02 PM | Iovance Biotherapeutics (Issuer) YARNO WENDY L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/13/2024 5:03 PM | Countouriotis Athena (Reporting) Iovance Biotherapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/11/2024 4:15 PM | Iovance Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/05/2024 7:07 PM | GRAF FINCKENSTEIN FRIEDRICH (Reporting) Iovance Biotherapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/05/2024 7:04 PM | Iovance Biotherapeutics (Issuer) Vogt Frederick G (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/05/2024 7:05 PM | BILINSKY IGOR (Reporting) Iovance Biotherapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/03/2024 7:01 AM | Iovance Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/17/2024 4:15 PM | Iovance Biotherapeutics (Filer)
| Form DEFA14A | |
05/01/2024 4:05 PM | Iovance Biotherapeutics (Filer)
| Form ARS | |
04/29/2024 4:06 PM | Iovance Biotherapeutics (Filer)
| Form DEF 14A | |
04/29/2024 4:07 PM | Iovance Biotherapeutics (Filer)
| Form DEFA14A | |
04/17/2024 6:07 PM | BILINSKY IGOR (Reporting) Iovance Biotherapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/17/2024 6:07 PM | GRAF FINCKENSTEIN FRIEDRICH (Reporting) Iovance Biotherapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/17/2024 6:08 PM | Iovance Biotherapeutics (Issuer) Vogt Frederick G (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/29/2024 4:00 PM | Iovance Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/06/2024 5:19 PM | Iovance Biotherapeutics (Issuer) Vogt Frederick G (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/06/2024 5:20 PM | GRAF FINCKENSTEIN FRIEDRICH (Reporting) Iovance Biotherapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/06/2024 5:17 PM | BILINSKY IGOR (Reporting) Iovance Biotherapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 4:58 PM | Iovance Biotherapeutics (Issuer) YARNO WENDY L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 4:50 PM | Countouriotis Athena (Reporting) Iovance Biotherapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 4:51 PM | Bellemin Jean-Marc (Reporting) Iovance Biotherapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 4:52 PM | BILINSKY IGOR (Reporting) Iovance Biotherapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/04/2024 7:00 AM | Iovance Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/01/2024 6:09 PM | Iovance Biotherapeutics (Subject) PERCEPTIVE ADVISORS LLC (Filed by)
| Form SC 13G | |
02/29/2024 6:30 AM | Iovance Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/28/2024 3:05 PM | Iovance Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/21/2024 3:44 PM | Iovance Biotherapeutics (Filer)
| Form 424B5 | |
02/20/2024 6:52 PM | Iovance Biotherapeutics (Issuer) MCPEAK MERRILL A (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
Tim Sykes’ Urgent Trade Alert: “Make this move now” (Ad) WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock
This $2 trillion D.C. shock is NOT about Trump or Biden dropping out of the race…![](https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx?TriggeredCampaignID=9318&Placement=NativeDisplay&Source=NativeDisplay) Click here to see a unique election-year trade |
02/20/2024 4:23 PM | Iovance Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/20/2024 5:03 AM | Iovance Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/14/2024 5:16 AM | Iovance Biotherapeutics (Subject) Point72 Asset Management, L.P. (Filed by)
| Form SC 13G/A | |
02/09/2024 4:40 PM | Iovance Biotherapeutics (Subject) MHR FUND MANAGEMENT LLC (Filed by)
| Form SC 13G/A | |
01/25/2024 9:49 AM | Iovance Biotherapeutics (Subject) STATE STREET CORP (Filed by)
| Form SC 13G/A | |
01/18/2024 5:07 PM | BILINSKY IGOR (Reporting) Iovance Biotherapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/18/2024 5:09 PM | GRAF FINCKENSTEIN FRIEDRICH (Reporting) Iovance Biotherapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/18/2024 5:09 PM | Iovance Biotherapeutics (Issuer) Vogt Frederick G (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/08/2024 4:03 PM | Iovance Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/27/2023 4:00 PM | Iovance Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/07/2023 4:15 PM | Iovance Biotherapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
10/27/2023 3:24 PM | Iovance Biotherapeutics (Subject) Quogue Capital LLC (Filed by)
| Form SC 13D/A | |
10/18/2023 7:03 PM | GRAF FINCKENSTEIN FRIEDRICH (Reporting) Iovance Biotherapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/18/2023 7:04 PM | BILINSKY IGOR (Reporting) Iovance Biotherapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/18/2023 7:05 PM | Iovance Biotherapeutics (Issuer) Vogt Frederick G (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/19/2023 3:30 PM | Iovance Biotherapeutics (Issuer) MCPEAK MERRILL A (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/15/2023 5:12 PM | Iovance Biotherapeutics (Issuer) Rothbaum Wayne P. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/15/2023 7:17 AM | Iovance Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |